Globorisk
Globorisk country-specific CVD risk score
#17
coverage rank
Global (country-recalibrated, 182 countries)201510-yearFatal + non-fatal CVD (CHD, stroke)7 inputs
Adults 40-74 without CVD
6
atlas factors covered
5
strongly-evidenced (A/B)
5
of 15 categories
Strengths
- Explicitly recalibrated to 182 countries using national risk-factor and mortality data
- Designed for global/low-resource use; laboratory and office-based versions
Weaknesses
- Small traditional-factor set (age, sex, smoking, SBP, TC, glucose)
- No HDL, renal, family history, imaging, or inflammatory inputs
- Calibration depends on quality of country-level input data
Input variables (7)
| Input | Maps to atlas factor | Category | Grade | Note |
|---|---|---|---|---|
| Age | Age | Demographic & Social | A | |
| Sex | Sex | Demographic & Social | C | |
| Current smoking | Cigarette smoking | Lifestyle & Behavioral | A | |
| Systolic blood pressure | Systolic blood pressure | Blood Pressure & Hemodynamics | A | |
| Total cholesterol | Total cholesterol | Lipids & Lipoproteins | A | |
| Diabetes / fasting glucose | Fasting plasma glucose | Glycemic & Metabolic | A | |
| Country/region calibration | — derived / not in atlas | — | — | population/geography calibration term, not an individual factor |
References
- A novel risk score to predict cardiovascular disease risk in national populations (Globorisk) — Lancet Diabetes Endocrinol 2015 · PMID 25819778